Saplyak, thanks for the chart. I do feel OPHI is a compelling buy at these levels, but for the sake of realism, note that your chart's $5 projection is based heavily on pre-reverse-merger data from 2009 of the previous incarnation of this shell, AMSZ, and the long slide in price AMSZ took as mgmt gradually revealed themselves as con men.
OPHI is a completely different company run by completely different management.
The only thing OPHI and AMSZ share is legacy trading data that, imo, should have been decoupled from the OPHI ticker history at the time of RM.
As such, the highs of $5 in 2009 have nothing to do with OPHI or its future prospects.
imo, Objective, scientific TA for OPHI can only use data back to the RM.
That said, I do see tremendous potential here, if the company comes through with the audited financials and continues expanding distribution.
News 
Market Data 
Discover 
AI
